KATHMANDU, May 18: Stroke remains a significant public health issue, but advances over the past two decades have transformed its treatment landscape, particularly in developed nations. Thanks to new treatment technologies and pharmaceutical developments, the incidents of stroke are declining in these countries.
UB’s Clinical and Translational Science Institute (CTSI) has awarded 13 new grants to support innovative translational research projects in Western New York. The CTSI Translational Pilot Studies Program provides seed money to investigators to assist them in developing promising new technologies and therapeutics from the conceptual stage to clinical studies.
“The pilot studies grant awardees for 2021-22 include projects that address significant translational research questions,” says CTSI Pilot Studies Program Director Brahm Segal, chair of the Department of Internal Medicine, chief of the Division of Infectious Diseases, and professor of oncology at Roswell Park Comprehensive Cancer Center. “In addition to developing new methods and technologies, these projects will foster cross-disciplinary collaborations and mentoring relationships.”